When a cell culture system from a 200L pilot tank is transferred “proportionally” to a 2000L pilot tank, fluctuations in yield, metabolic disturbances, and apoptosis are often not simply due to operational errors. Behind these phenomena lies a systemic challenge caused by scale effects. As the size of the equipment increases, the physical field, transport processes, and cellular microenvironment undergo nonlinear changes.
I. Core Contradictions in Scale-up Traditional scale-up thinking often assumes that parameters in a large tank are simply multiples of those in a small tank, neglecting the qualitative changes in system properties brought about by volume increases.
From the perspective of engineering thermodynamics and bioprocess engineering, the core contradictions in scale-up are mainly three:
KNIK BIO 20L 200L cell bioreactor
1. Different Oxygen Transfer: Oxygen transfer efficiency (kLa) is affected by multiple factors, including aeration rate, stirring shear force, and tank geometry.
2. Different Flow Field Distributions: Completely mixed flow within a small tank is difficult to maintain at a scale of 2000L, and stirring blind zones lead to dead zones. When the shear force gradient difference widens, the risk of cell breakage increases, and the probability of protein aggregation rises.
3. Different Microenvironments: The spatial limitations of pH probes lead to detection blind zones, and CO₂ accumulation causes intracellular acidosis, inhibiting antibody synthesis. These “invisible variables” become key factors in yield fluctuations.
KNIK BIO 1000L cell bioreactor
II. Currently Commonly Used Scale-Up Methods The “multi-scale coupling + digital twin” approach is commonly employed, employing laboratory modeling → pilot-scale verification → production optimization to reduce scale-up risks.The specific implementation can be divided into three stages:
1. Pilot-scale stage: Building a predictive model • Screening key process parameters (CPPs) using DOE * Measuring kLa using the dynamic dissolved oxygen method and plotting the “kLa-scale” curve • Simulating the flow field distribution using a scaled-down model and optimizing the impeller design
2. Pilot-scale stage: Digital twin verification • Real-time monitoring of Raman spectroscopy, near-infrared, and other data • CFD simulation revealing flow field distribution characteristics • Comparing the virtual model with measured data and correcting parameters
3. Production stage: Continuous process verification • Monitoring indirect indicators such as cell apoptosis rate and glycosylation modification • Iterative updates to the knowledge base to support larger-scale production
Large scale cell bioreactor from KNIKbio
III. Practical Recommendations During the small-scale test phase, it is recommended to include scalability assessments, prioritizing the measurement of core parameters such as kLa, mixing time, and shear force.
Before the pilot-scale test, consider using CFD to construct a flow field model, focusing on the dead zone ratio and shear force distribution.
Finally, gradually establish a scale effect database to record the parameter variation patterns at different scales.